

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive thymic T cell selection (GO:0045059) | 7.71754142 |
| 2 | cellular response to interleukin-15 (GO:0071350) | 7.62610720 |
| 3 | negative thymic T cell selection (GO:0045060) | 7.48976537 |
| 4 | negative T cell selection (GO:0043383) | 7.48884085 |
| 5 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 7.21819026 |
| 6 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.94964346 |
| 7 | thymic T cell selection (GO:0045061) | 6.93373822 |
| 8 | cytidine deamination (GO:0009972) | 6.74382209 |
| 9 | cytidine metabolic process (GO:0046087) | 6.74382209 |
| 10 | cytidine catabolic process (GO:0006216) | 6.74382209 |
| 11 | sequestering of actin monomers (GO:0042989) | 6.69643288 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.69575228 |
| 13 | response to interleukin-15 (GO:0070672) | 6.66789608 |
| 14 | interferon-gamma production (GO:0032609) | 6.60986988 |
| 15 | leukocyte aggregation (GO:0070486) | 6.60303710 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.54160172 |
| 17 | positive T cell selection (GO:0043368) | 6.47336967 |
| 18 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.05108913 |
| 19 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.88295153 |
| 20 | T cell migration (GO:0072678) | 5.79844120 |
| 21 | negative regulation of cell killing (GO:0031342) | 5.71067025 |
| 22 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.71067025 |
| 23 | T cell selection (GO:0045058) | 5.67717275 |
| 24 | T cell receptor signaling pathway (GO:0050852) | 5.65889397 |
| 25 | T cell costimulation (GO:0031295) | 5.63929598 |
| 26 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.62672732 |
| 27 | lymphocyte costimulation (GO:0031294) | 5.60289372 |
| 28 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.50631139 |
| 29 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 5.49350497 |
| 30 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 5.49350497 |
| 31 | regulation of T cell tolerance induction (GO:0002664) | 5.47564105 |
| 32 | regulation of natural killer cell mediated immunity (GO:0002715) | 5.46451999 |
| 33 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 5.46451999 |
| 34 | regulation of T cell receptor signaling pathway (GO:0050856) | 5.34111159 |
| 35 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 5.18379145 |
| 36 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.91157428 |
| 37 | regulation of gamma-delta T cell activation (GO:0046643) | 4.90201880 |
| 38 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.89631203 |
| 39 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.88444961 |
| 40 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.88187334 |
| 41 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.80280861 |
| 42 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.73852483 |
| 43 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.63904979 |
| 44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.63904979 |
| 45 | positive regulation of tolerance induction (GO:0002645) | 4.54524508 |
| 46 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.47157209 |
| 47 | regulation of immunoglobulin mediated immune response (GO:0002889) | 4.47069955 |
| 48 | regulation of activation of Janus kinase activity (GO:0010533) | 4.46046417 |
| 49 | positive regulation of lamellipodium assembly (GO:0010592) | 4.43665394 |
| 50 | positive regulation of B cell mediated immunity (GO:0002714) | 4.38170892 |
| 51 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 4.38170892 |
| 52 | regulation of B cell mediated immunity (GO:0002712) | 4.32281059 |
| 53 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.32195631 |
| 54 | positive regulation of cell killing (GO:0031343) | 4.26421729 |
| 55 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 4.24755668 |
| 56 | natural killer cell activation (GO:0030101) | 4.22219327 |
| 57 | regulation of cell killing (GO:0031341) | 4.19697950 |
| 58 | negative regulation of T cell apoptotic process (GO:0070233) | 4.17950173 |
| 59 | DNA deamination (GO:0045006) | 4.14629365 |
| 60 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 4.08614714 |
| 61 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.08510792 |
| 62 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.99633851 |
| 63 | positive regulation of macrophage differentiation (GO:0045651) | 3.98181056 |
| 64 | regulation of response to interferon-gamma (GO:0060330) | 3.94478529 |
| 65 | positive regulation of B cell differentiation (GO:0045579) | 3.93195220 |
| 66 | regulation of tolerance induction (GO:0002643) | 3.92539985 |
| 67 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.88847533 |
| 68 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.88632511 |
| 69 | positive regulation of isotype switching (GO:0045830) | 3.88183872 |
| 70 | regulation of isotype switching (GO:0045191) | 3.87496292 |
| 71 | mast cell activation (GO:0045576) | 3.85933953 |
| 72 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.84472814 |
| 73 | negative regulation of T cell mediated immunity (GO:0002710) | 3.80295237 |
| 74 | cellular response to zinc ion (GO:0071294) | 3.79859014 |
| 75 | cellular defense response (GO:0006968) | 3.78264376 |
| 76 | lymphocyte migration (GO:0072676) | 3.78027522 |
| 77 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.73565628 |
| 78 | type I interferon signaling pathway (GO:0060337) | 3.72449397 |
| 79 | cellular response to type I interferon (GO:0071357) | 3.72449397 |
| 80 | response to type I interferon (GO:0034340) | 3.71820019 |
| 81 | positive regulation of defense response to virus by host (GO:0002230) | 3.71577427 |
| 82 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.71355157 |
| 83 | negative regulation of B cell mediated immunity (GO:0002713) | 3.71355157 |
| 84 | regulation of B cell differentiation (GO:0045577) | 3.70125796 |
| 85 | positive regulation of lamellipodium organization (GO:1902745) | 3.68636349 |
| 86 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.67921606 |
| 87 | actin nucleation (GO:0045010) | 3.67167268 |
| 88 | cellular extravasation (GO:0045123) | 3.65921645 |
| 89 | negative regulation by host of viral transcription (GO:0043922) | 3.64564947 |
| 90 | regulation of respiratory burst (GO:0060263) | 3.61783131 |
| 91 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.57955853 |
| 92 | granulocyte activation (GO:0036230) | 3.57655039 |
| 93 | regulation of regulatory T cell differentiation (GO:0045589) | 3.56085770 |
| 94 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.52321911 |
| 95 | neutrophil activation (GO:0042119) | 3.51343432 |
| 96 | regulation of response to tumor cell (GO:0002834) | 3.51058426 |
| 97 | positive regulation of response to tumor cell (GO:0002836) | 3.51058426 |
| 98 | positive regulation of immune response to tumor cell (GO:0002839) | 3.51058426 |
| 99 | regulation of immune response to tumor cell (GO:0002837) | 3.51058426 |
| 100 | leukocyte cell-cell adhesion (GO:0007159) | 3.46397083 |
| 101 | positive regulation of DNA recombination (GO:0045911) | 3.43614437 |
| 102 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.40213240 |
| 103 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.40161326 |
| 104 | regulation of immunoglobulin production (GO:0002637) | 3.39292012 |
| 105 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.38927552 |
| 106 | lymphocyte chemotaxis (GO:0048247) | 3.38015149 |
| 107 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.37560961 |
| 108 | leukocyte degranulation (GO:0043299) | 3.35049763 |
| 109 | T cell activation (GO:0042110) | 3.35045957 |
| 110 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.33030987 |
| 111 | T cell differentiation (GO:0030217) | 3.32682388 |
| 112 | negative regulation of viral genome replication (GO:0045071) | 3.32191783 |
| 113 | positive regulation of immunoglobulin production (GO:0002639) | 3.31545151 |
| 114 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.31389493 |
| 115 | Peyers patch development (GO:0048541) | 3.31389493 |
| 116 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.27039734 |
| 117 | negative regulation of type 2 immune response (GO:0002829) | 3.26015593 |
| 118 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.25956970 |
| 119 | activated T cell proliferation (GO:0050798) | 3.25590508 |
| 120 | immunoglobulin mediated immune response (GO:0016064) | 3.24185016 |
| 121 | cellular response to interleukin-4 (GO:0071353) | 3.23818891 |
| 122 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.22938577 |
| 123 | dendritic cell chemotaxis (GO:0002407) | 3.22008323 |
| 124 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.20587321 |
| 125 | positive regulation of T cell mediated immunity (GO:0002711) | 3.19942705 |
| 126 | positive regulation of lymphocyte migration (GO:2000403) | 3.13093141 |
| 127 | regulation of T cell chemotaxis (GO:0010819) | 3.11230485 |
| 128 | positive regulation of T cell chemotaxis (GO:0010820) | 3.11230485 |
| 129 | mast cell activation involved in immune response (GO:0002279) | 3.09293995 |
| 130 | mast cell degranulation (GO:0043303) | 3.09293995 |
| 131 | neutrophil activation involved in immune response (GO:0002283) | 3.07770254 |
| 132 | negative regulation of innate immune response (GO:0045824) | 3.06260611 |
| 133 | positive regulation of granulocyte differentiation (GO:0030854) | 3.02292304 |
| 134 | regulation of T cell mediated immunity (GO:0002709) | 3.01783640 |
| 135 | regulation of T cell apoptotic process (GO:0070232) | 3.01592172 |
| 136 | response to interferon-beta (GO:0035456) | 3.00122830 |
| 137 | B cell mediated immunity (GO:0019724) | 2.99361461 |
| 138 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.97179721 |
| 139 | macrophage chemotaxis (GO:0048246) | 2.93690167 |
| 140 | cytolysis (GO:0019835) | 2.93194471 |
| 141 | regulation of memory T cell differentiation (GO:0043380) | 2.92888210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.79203650 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.08899579 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.48128386 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.32873610 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.06860513 |
| 6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.06605040 |
| 7 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 4.01849325 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.43603156 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.34869835 |
| 10 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.33517376 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.22851245 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 3.22759178 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.17438780 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 3.10529229 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.00346128 |
| 16 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.84736880 |
| 17 | * MYB_26560356_Chip-Seq_TH1_Human | 2.79442658 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.68863099 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.46660410 |
| 20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.43013331 |
| 21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42996615 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.41157398 |
| 23 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.32554022 |
| 24 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.29989136 |
| 25 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.13819413 |
| 26 | MAF_26560356_Chip-Seq_TH2_Human | 2.10825766 |
| 27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.05716283 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.03675686 |
| 29 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.93779112 |
| 30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86835124 |
| 31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.86292567 |
| 32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.76457495 |
| 33 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.74012209 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72673085 |
| 35 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69913277 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.66170631 |
| 37 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.64242017 |
| 38 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62972556 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.57780650 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.54558791 |
| 41 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.49844645 |
| 42 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.44085726 |
| 43 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42969996 |
| 44 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.42422876 |
| 45 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.40815635 |
| 46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40193834 |
| 47 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.39566342 |
| 48 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.37968985 |
| 49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.36784192 |
| 50 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.34811584 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30625575 |
| 52 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29757363 |
| 53 | GATA3_26560356_Chip-Seq_TH2_Human | 1.29280760 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24241735 |
| 55 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.23365224 |
| 56 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.23205440 |
| 57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.22242682 |
| 58 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.21815901 |
| 59 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.20712983 |
| 60 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20007560 |
| 61 | SPI1_23127762_ChIP-Seq_K562_Human | 1.19202620 |
| 62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16417959 |
| 63 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15117779 |
| 64 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.15088931 |
| 65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13939057 |
| 66 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12498974 |
| 67 | P300_27268052_Chip-Seq_Bcells_Human | 1.08772375 |
| 68 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.08567648 |
| 69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07620078 |
| 70 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07000885 |
| 71 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06149702 |
| 72 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06140271 |
| 73 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.05754410 |
| 74 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.05646633 |
| 75 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05429800 |
| 76 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03674067 |
| 77 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02659798 |
| 78 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.02459143 |
| 79 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.01447858 |
| 80 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00707922 |
| 81 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.98861170 |
| 82 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.98596106 |
| 83 | GATA3_26560356_Chip-Seq_TH1_Human | 0.97769435 |
| 84 | GATA1_22025678_ChIP-Seq_K562_Human | 0.96990945 |
| 85 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96633806 |
| 86 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.94545341 |
| 87 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91789895 |
| 88 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89960619 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89898624 |
| 90 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.89446902 |
| 91 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89058151 |
| 92 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.88543176 |
| 93 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88094294 |
| 94 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.88057484 |
| 95 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.87478135 |
| 96 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.87319111 |
| 97 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.87164439 |
| 98 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.85944694 |
| 99 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85798704 |
| 100 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.83954845 |
| 101 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.82187932 |
| 102 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.82005574 |
| 103 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81579462 |
| 104 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80126997 |
| 105 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79441932 |
| 106 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78610608 |
| 107 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.78432257 |
| 108 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.78212326 |
| 109 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.77760386 |
| 110 | * FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.77646696 |
| 111 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.77608764 |
| 112 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.77537667 |
| 113 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.76564919 |
| 114 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.74418487 |
| 115 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.74184541 |
| 116 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.73947681 |
| 117 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73849056 |
| 118 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.73555188 |
| 119 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73011033 |
| 120 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.72290261 |
| 121 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.70497568 |
| 122 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.70044561 |
| 123 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.69210237 |
| 124 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.68984028 |
| 125 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.67891588 |
| 126 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.67346271 |
| 127 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.65348044 |
| 128 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.63413688 |
| 129 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.62727029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.14863128 |
| 2 | MP0003763_abnormal_thymus_physiology | 5.73304532 |
| 3 | MP0009785_altered_susceptibility_to | 4.21282628 |
| 4 | MP0006082_CNS_inflammation | 3.80388077 |
| 5 | MP0002166_altered_tumor_susceptibility | 3.61134408 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.49636950 |
| 7 | MP0000685_abnormal_immune_system | 3.18139507 |
| 8 | MP0001800_abnormal_humoral_immune | 3.11868795 |
| 9 | MP0002006_tumorigenesis | 3.10831109 |
| 10 | MP0005025_abnormal_response_to | 3.05515797 |
| 11 | MP0002420_abnormal_adaptive_immunity | 3.02553584 |
| 12 | MP0001819_abnormal_immune_cell | 3.01214118 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.91382492 |
| 14 | MP0002723_abnormal_immune_serum | 2.90459628 |
| 15 | MP0002398_abnormal_bone_marrow | 2.80074854 |
| 16 | MP0001790_abnormal_immune_system | 2.77493657 |
| 17 | MP0005387_immune_system_phenotype | 2.77493657 |
| 18 | MP0003724_increased_susceptibility_to | 2.71784456 |
| 19 | MP0002405_respiratory_system_inflammati | 2.63894684 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 2.58381441 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.55746082 |
| 22 | MP0000703_abnormal_thymus_morphology | 2.48855917 |
| 23 | MP0004947_skin_inflammation | 2.48667894 |
| 24 | MP0000716_abnormal_immune_system | 2.48434460 |
| 25 | MP0002722_abnormal_immune_system | 2.41388618 |
| 26 | MP0000689_abnormal_spleen_morphology | 2.19088677 |
| 27 | MP0002933_joint_inflammation | 2.18205315 |
| 28 | MP0001873_stomach_inflammation | 2.10294736 |
| 29 | MP0010155_abnormal_intestine_physiology | 2.09852742 |
| 30 | MP0002429_abnormal_blood_cell | 1.97088875 |
| 31 | MP0002419_abnormal_innate_immunity | 1.93042902 |
| 32 | MP0000858_altered_metastatic_potential | 1.92308299 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.83953145 |
| 34 | MP0003436_decreased_susceptibility_to | 1.81103353 |
| 35 | MP0003866_abnormal_defecation | 1.74098209 |
| 36 | MP0002396_abnormal_hematopoietic_system | 1.72289259 |
| 37 | MP0003448_altered_tumor_morphology | 1.71261946 |
| 38 | MP0004381_abnormal_hair_follicle | 1.67636140 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.67427468 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.61245541 |
| 41 | MP0002009_preneoplasia | 1.60975457 |
| 42 | MP0004510_myositis | 1.56198471 |
| 43 | MP0005310_abnormal_salivary_gland | 1.51419543 |
| 44 | MP0002132_abnormal_respiratory_system | 1.46980213 |
| 45 | MP0001851_eye_inflammation | 1.42886076 |
| 46 | MP0008469_abnormal_protein_level | 1.30835916 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.30067520 |
| 48 | MP0002019_abnormal_tumor_incidence | 1.19663654 |
| 49 | MP0003045_fibrosis | 1.19290716 |
| 50 | MP0001853_heart_inflammation | 1.08163423 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.05467062 |
| 52 | MP0000490_abnormal_crypts_of | 1.03876576 |
| 53 | MP0009763_increased_sensitivity_to | 1.00862112 |
| 54 | MP0001533_abnormal_skeleton_physiology | 0.99242458 |
| 55 | MP0001986_abnormal_taste_sensitivity | 0.96711724 |
| 56 | MP0009764_decreased_sensitivity_to | 0.92658895 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 0.88896486 |
| 58 | MP0003183_abnormal_peptide_metabolism | 0.87786485 |
| 59 | MP0003786_premature_aging | 0.81546431 |
| 60 | MP0010234_abnormal_vibrissa_follicle | 0.81528959 |
| 61 | MP0005075_abnormal_melanosome_morpholog | 0.81451186 |
| 62 | MP0008872_abnormal_physiological_respon | 0.80382404 |
| 63 | MP0005023_abnormal_wound_healing | 0.80303233 |
| 64 | MP0003075_altered_response_to | 0.78891110 |
| 65 | MP0002876_abnormal_thyroid_physiology | 0.78772329 |
| 66 | MP0000343_altered_response_to | 0.77452317 |
| 67 | MP0001765_abnormal_ion_homeostasis | 0.77190906 |
| 68 | MP0001905_abnormal_dopamine_level | 0.73962796 |
| 69 | MP0008877_abnormal_DNA_methylation | 0.73864987 |
| 70 | MP0005451_abnormal_body_composition | 0.72480536 |
| 71 | MP0000477_abnormal_intestine_morphology | 0.70904474 |
| 72 | MP0003303_peritoneal_inflammation | 0.68848055 |
| 73 | MP0001501_abnormal_sleep_pattern | 0.68744999 |
| 74 | MP0002095_abnormal_skin_pigmentation | 0.68028355 |
| 75 | MP0009765_abnormal_xenobiotic_induced | 0.67139231 |
| 76 | MP0001191_abnormal_skin_condition | 0.66975347 |
| 77 | MP0003878_abnormal_ear_physiology | 0.65853074 |
| 78 | MP0005377_hearing/vestibular/ear_phenot | 0.65853074 |
| 79 | MP0003806_abnormal_nucleotide_metabolis | 0.65235566 |
| 80 | MP0004808_abnormal_hematopoietic_stem | 0.64025464 |
| 81 | MP0000465_gastrointestinal_hemorrhage | 0.63636490 |
| 82 | MP0005410_abnormal_fertilization | 0.62468046 |
| 83 | MP0004145_abnormal_muscle_electrophysio | 0.60974301 |
| 84 | MP0005083_abnormal_biliary_tract | 0.60863029 |
| 85 | MP0000015_abnormal_ear_pigmentation | 0.60771437 |
| 86 | MP0008007_abnormal_cellular_replicative | 0.60553521 |
| 87 | MP0001243_abnormal_dermal_layer | 0.60345020 |
| 88 | MP0001881_abnormal_mammary_gland | 0.60176250 |
| 89 | MP0002138_abnormal_hepatobiliary_system | 0.58998369 |
| 90 | MP0005166_decreased_susceptibility_to | 0.57785203 |
| 91 | MP0003638_abnormal_response/metabolism_ | 0.57694832 |
| 92 | MP0001348_abnormal_lacrimal_gland | 0.57266711 |
| 93 | MP0001919_abnormal_reproductive_system | 0.56888374 |
| 94 | MP0005084_abnormal_gallbladder_morpholo | 0.56439983 |
| 95 | MP0003252_abnormal_bile_duct | 0.55925870 |
| 96 | MP0005645_abnormal_hypothalamus_physiol | 0.55463012 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.54525565 |
| 98 | MP0004130_abnormal_muscle_cell | 0.54166674 |
| 99 | MP0009278_abnormal_bone_marrow | 0.52705748 |
| 100 | MP0006036_abnormal_mitochondrial_physio | 0.51940484 |
| 101 | MP0002163_abnormal_gland_morphology | 0.51549877 |
| 102 | MP0004147_increased_porphyrin_level | 0.51525954 |
| 103 | MP0003646_muscle_fatigue | 0.50763286 |
| 104 | MP0000613_abnormal_salivary_gland | 0.49274276 |
| 105 | MP0001216_abnormal_epidermal_layer | 0.48361851 |
| 106 | MP0000609_abnormal_liver_physiology | 0.47513930 |
| 107 | MP0003795_abnormal_bone_structure | 0.47360910 |
| 108 | MP0001663_abnormal_digestive_system | 0.46970517 |
| 109 | MP0002909_abnormal_adrenal_gland | 0.45787081 |
| 110 | MP0003453_abnormal_keratinocyte_physiol | 0.42594183 |
| 111 | MP0002928_abnormal_bile_duct | 0.41984416 |
| 112 | MP0000367_abnormal_coat/_hair | 0.40943109 |
| 113 | MP0002693_abnormal_pancreas_physiology | 0.40844712 |
| 114 | MP0000372_irregular_coat_pigmentation | 0.39602690 |
| 115 | MP0000249_abnormal_blood_vessel | 0.37815986 |
| 116 | MP0000920_abnormal_myelination | 0.37488548 |
| 117 | MP0004957_abnormal_blastocyst_morpholog | 0.37184317 |
| 118 | MP0005397_hematopoietic_system_phenotyp | 0.37036678 |
| 119 | MP0001545_abnormal_hematopoietic_system | 0.37036678 |
| 120 | MP0009643_abnormal_urine_homeostasis | 0.36974973 |
| 121 | MP0005174_abnormal_tail_pigmentation | 0.33743676 |
| 122 | MP0002083_premature_death | 0.33392593 |
| 123 | MP0003943_abnormal_hepatobiliary_system | 0.33296747 |
| 124 | MP0008873_increased_physiological_sensi | 0.31504995 |
| 125 | MP0000627_abnormal_mammary_gland | 0.31424120 |
| 126 | MP0003959_abnormal_lean_body | 0.31300603 |
| 127 | MP0005390_skeleton_phenotype | 0.30501147 |
| 128 | MP0000313_abnormal_cell_death | 0.28817958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Severe combined immunodeficiency (HP:0004430) | 7.75365941 |
| 2 | T lymphocytopenia (HP:0005403) | 7.41380099 |
| 3 | Abnormality of T cell number (HP:0011839) | 7.32332212 |
| 4 | Combined immunodeficiency (HP:0005387) | 6.89073370 |
| 5 | Autoimmune hemolytic anemia (HP:0001890) | 6.47728786 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.13973638 |
| 7 | Stomatitis (HP:0010280) | 5.83164665 |
| 8 | Recurrent bronchitis (HP:0002837) | 5.51827733 |
| 9 | Hypoplasia of the thymus (HP:0000778) | 5.50871126 |
| 10 | Thyroiditis (HP:0100646) | 5.44732877 |
| 11 | Chronic mucocutaneous candidiasis (HP:0002728) | 5.29771748 |
| 12 | Recurrent cutaneous fungal infections (HP:0011370) | 5.29771748 |
| 13 | Abnormality of T cells (HP:0002843) | 5.12373381 |
| 14 | IgG deficiency (HP:0004315) | 5.11590484 |
| 15 | Chronic diarrhea (HP:0002028) | 4.76554547 |
| 16 | Myositis (HP:0100614) | 4.57773605 |
| 17 | Recurrent fungal infections (HP:0002841) | 4.29646831 |
| 18 | Abnormality of eosinophils (HP:0001879) | 4.28114781 |
| 19 | Lymphopenia (HP:0001888) | 4.13779471 |
| 20 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.04134758 |
| 21 | Increased IgM level (HP:0003496) | 4.00827409 |
| 22 | IgM deficiency (HP:0002850) | 3.85160273 |
| 23 | Nasal polyposis (HP:0100582) | 3.80460770 |
| 24 | Optic neuritis (HP:0100653) | 3.78813121 |
| 25 | Retrobulbar optic neuritis (HP:0100654) | 3.78813121 |
| 26 | Eczematoid dermatitis (HP:0000976) | 3.78628306 |
| 27 | Leukocytosis (HP:0001974) | 3.69972371 |
| 28 | Agammaglobulinemia (HP:0004432) | 3.62134433 |
| 29 | Orchitis (HP:0100796) | 3.60524634 |
| 30 | Recurrent abscess formation (HP:0002722) | 3.59706332 |
| 31 | Aplastic anemia (HP:0001915) | 3.41728919 |
| 32 | Panhypogammaglobulinemia (HP:0003139) | 3.36251622 |
| 33 | Joint swelling (HP:0001386) | 3.36230366 |
| 34 | Abnormality of the nasal mucosa (HP:0000433) | 3.18037742 |
| 35 | Abnormality of T cell physiology (HP:0011840) | 3.12191709 |
| 36 | Prolonged bleeding time (HP:0003010) | 3.10666196 |
| 37 | Petechiae (HP:0000967) | 3.07569523 |
| 38 | Bronchitis (HP:0012387) | 3.04430195 |
| 39 | Recurrent skin infections (HP:0001581) | 3.03431340 |
| 40 | Chronic otitis media (HP:0000389) | 3.02547916 |
| 41 | Gastrointestinal infarctions (HP:0005244) | 2.96121927 |
| 42 | Meningitis (HP:0001287) | 2.95528139 |
| 43 | Recurrent sinusitis (HP:0011108) | 2.92712907 |
| 44 | Hemoptysis (HP:0002105) | 2.92508647 |
| 45 | Obstructive lung disease (HP:0006536) | 2.92499221 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.92499221 |
| 47 | Mediastinal lymphadenopathy (HP:0100721) | 2.84777296 |
| 48 | Pustule (HP:0200039) | 2.84114081 |
| 49 | Recurrent viral infections (HP:0004429) | 2.83225467 |
| 50 | Hemiplegia (HP:0002301) | 2.75945775 |
| 51 | Vasculitis (HP:0002633) | 2.73084523 |
| 52 | Muscle fiber atrophy (HP:0100295) | 2.69037229 |
| 53 | Keratoconjunctivitis sicca (HP:0001097) | 2.68836479 |
| 54 | Hypergammaglobulinemia (HP:0010702) | 2.68197293 |
| 55 | Pulmonary infiltrates (HP:0002113) | 2.66271533 |
| 56 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.64971819 |
| 57 | B lymphocytopenia (HP:0010976) | 2.55803612 |
| 58 | Abnormality of B cell number (HP:0010975) | 2.55803612 |
| 59 | Encephalitis (HP:0002383) | 2.55470550 |
| 60 | Recurrent otitis media (HP:0000403) | 2.55034160 |
| 61 | Hypoproteinemia (HP:0003075) | 2.54884470 |
| 62 | Lymphoma (HP:0002665) | 2.54306063 |
| 63 | Gingivitis (HP:0000230) | 2.47214886 |
| 64 | Eosinophilia (HP:0001880) | 2.46504691 |
| 65 | Renal cortical cysts (HP:0000803) | 2.41364153 |
| 66 | Keratoconjunctivitis (HP:0001096) | 2.41324284 |
| 67 | Microcytic anemia (HP:0001935) | 2.38821196 |
| 68 | Purpura (HP:0000979) | 2.35673952 |
| 69 | Type 2 muscle fiber atrophy (HP:0003554) | 2.35605038 |
| 70 | Gangrene (HP:0100758) | 2.32079906 |
| 71 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.31455541 |
| 72 | Gingival bleeding (HP:0000225) | 2.26137050 |
| 73 | Increased serum ferritin (HP:0003281) | 2.23667643 |
| 74 | Arterial thrombosis (HP:0004420) | 2.21958322 |
| 75 | 3-Methylglutaconic aciduria (HP:0003535) | 2.21638792 |
| 76 | Alveolar cell carcinoma (HP:0006519) | 2.20620483 |
| 77 | Amyotrophic lateral sclerosis (HP:0007354) | 2.18428627 |
| 78 | Entropion (HP:0000621) | 2.15342864 |
| 79 | Poikiloderma (HP:0001029) | 2.13080431 |
| 80 | Acute hepatic failure (HP:0006554) | 2.11581423 |
| 81 | Abnormality of iron homeostasis (HP:0011031) | 2.10305070 |
| 82 | Abnormality of the fingertips (HP:0001211) | 2.09385277 |
| 83 | Granulocytopenia (HP:0001913) | 2.08889697 |
| 84 | Cheilitis (HP:0100825) | 2.08510324 |
| 85 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.07265428 |
| 86 | Pulmonary embolism (HP:0002204) | 2.06094661 |
| 87 | Skin rash (HP:0000988) | 2.04888684 |
| 88 | Pulmonary fibrosis (HP:0002206) | 2.03815290 |
| 89 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.03177946 |
| 90 | Hypochromic anemia (HP:0001931) | 2.00637835 |
| 91 | Urticaria (HP:0001025) | 1.99396663 |
| 92 | Autoimmune thrombocytopenia (HP:0001973) | 1.99317084 |
| 93 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98586862 |
| 94 | Stomach cancer (HP:0012126) | 1.98243053 |
| 95 | Episodic fever (HP:0001954) | 1.97691151 |
| 96 | Anorexia (HP:0002039) | 1.97567039 |
| 97 | Inflammation of the large intestine (HP:0002037) | 1.94219817 |
| 98 | Abolished electroretinogram (ERG) (HP:0000550) | 1.92832283 |
| 99 | Abnormality of the prostate (HP:0008775) | 1.92770241 |
| 100 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.90727671 |
| 101 | Epistaxis (HP:0000421) | 1.90435668 |
| 102 | Pancytopenia (HP:0001876) | 1.86680433 |
| 103 | Vertigo (HP:0002321) | 1.86440780 |
| 104 | Glomerulopathy (HP:0100820) | 1.85920964 |
| 105 | Ureteral stenosis (HP:0000071) | 1.85487751 |
| 106 | Gastrointestinal inflammation (HP:0004386) | 1.85403379 |
| 107 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.84847694 |
| 108 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.84687863 |
| 109 | Sepsis (HP:0100806) | 1.83433896 |
| 110 | Recurrent bacterial skin infections (HP:0005406) | 1.82453861 |
| 111 | Hepatosplenomegaly (HP:0001433) | 1.81115446 |
| 112 | IgA deficiency (HP:0002720) | 1.78557075 |
| 113 | Basal cell carcinoma (HP:0002671) | 1.78461270 |
| 114 | Premature graying of hair (HP:0002216) | 1.77881259 |
| 115 | Keratitis (HP:0000491) | 1.77592031 |
| 116 | Anhidrosis (HP:0000970) | 1.77473320 |
| 117 | Large eyes (HP:0001090) | 1.76910504 |
| 118 | Hypoalbuminemia (HP:0003073) | 1.74167678 |
| 119 | Abnormal albumin level (HP:0012116) | 1.74167678 |
| 120 | Abnormality of the pleura (HP:0002103) | 1.74108678 |
| 121 | Abnormality of oral frenula (HP:0000190) | 1.73521767 |
| 122 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.71954467 |
| 123 | Spontaneous hematomas (HP:0007420) | 1.71636320 |
| 124 | Thrombocytosis (HP:0001894) | 1.70853551 |
| 125 | Increased IgE level (HP:0003212) | 1.70148816 |
| 126 | Abnormality of macrophages (HP:0004311) | 1.69638967 |
| 127 | Chest pain (HP:0100749) | 1.69279120 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.02295680 |
| 2 | MAP4K1 | 4.88334488 |
| 3 | KDR | 4.65920991 |
| 4 | IKBKE | 3.50526111 |
| 5 | TESK2 | 3.42336156 |
| 6 | TAOK3 | 3.41810141 |
| 7 | ZAP70 | 3.37457991 |
| 8 | FGFR4 | 3.34598106 |
| 9 | ITK | 3.33070649 |
| 10 | BCKDK | 2.81816410 |
| 11 | TYK2 | 2.64479389 |
| 12 | JAK3 | 2.62728350 |
| 13 | TBK1 | 2.54425462 |
| 14 | MAP3K12 | 2.25133360 |
| 15 | JAK1 | 2.24178910 |
| 16 | RIPK4 | 2.19828112 |
| 17 | LCK | 2.18653015 |
| 18 | BLK | 1.87473615 |
| 19 | TEC | 1.83309337 |
| 20 | KIT | 1.80649489 |
| 21 | FGFR3 | 1.71047777 |
| 22 | MAP3K14 | 1.62860494 |
| 23 | STK10 | 1.62469241 |
| 24 | NME2 | 1.61722648 |
| 25 | MAP4K2 | 1.53372080 |
| 26 | BTK | 1.52195346 |
| 27 | TLK1 | 1.51581624 |
| 28 | MST4 | 1.42533365 |
| 29 | CSK | 1.42214627 |
| 30 | SYK | 1.41824907 |
| 31 | BMPR2 | 1.40553219 |
| 32 | GRK6 | 1.33002610 |
| 33 | TESK1 | 1.30493870 |
| 34 | HCK | 1.28075949 |
| 35 | NUAK1 | 1.28048711 |
| 36 | IRAK4 | 1.24264013 |
| 37 | MATK | 1.13975445 |
| 38 | LYN | 1.09400469 |
| 39 | MAP2K6 | 1.08932963 |
| 40 | PRKCH | 1.08208678 |
| 41 | PRKCQ | 1.06527836 |
| 42 | MARK3 | 1.05452163 |
| 43 | VRK2 | 1.05186440 |
| 44 | MAP3K13 | 1.03026929 |
| 45 | CLK1 | 1.02045032 |
| 46 | NLK | 0.98744080 |
| 47 | PIK3CG | 0.95892785 |
| 48 | MAP2K2 | 0.95849371 |
| 49 | LRRK2 | 0.94680895 |
| 50 | TNK2 | 0.94091064 |
| 51 | BUB1 | 0.84707327 |
| 52 | IKBKB | 0.78861771 |
| 53 | FYN | 0.77544389 |
| 54 | ZAK | 0.77263154 |
| 55 | CAMKK2 | 0.75912423 |
| 56 | NEK9 | 0.74522057 |
| 57 | ACVR1B | 0.73993053 |
| 58 | FGFR1 | 0.69352048 |
| 59 | MYLK | 0.67366729 |
| 60 | MAPK11 | 0.67079665 |
| 61 | PIK3CA | 0.66971831 |
| 62 | CDK3 | 0.66388652 |
| 63 | RPS6KA4 | 0.64743397 |
| 64 | TAOK1 | 0.63221529 |
| 65 | DAPK3 | 0.61077024 |
| 66 | INSR | 0.59446074 |
| 67 | LIMK1 | 0.57987491 |
| 68 | IGF1R | 0.57625034 |
| 69 | GRK5 | 0.50047345 |
| 70 | CSF1R | 0.49960364 |
| 71 | FES | 0.49659358 |
| 72 | MUSK | 0.49093198 |
| 73 | SCYL2 | 0.48028404 |
| 74 | GRK1 | 0.47427810 |
| 75 | EEF2K | 0.46885578 |
| 76 | BRD4 | 0.46728920 |
| 77 | JAK2 | 0.46480111 |
| 78 | MAPKAPK2 | 0.45040156 |
| 79 | VRK1 | 0.44457470 |
| 80 | PIM1 | 0.43092008 |
| 81 | TGFBR2 | 0.42290269 |
| 82 | MAP3K10 | 0.42187881 |
| 83 | ADRBK1 | 0.41225485 |
| 84 | ERN1 | 0.39865191 |
| 85 | EIF2AK2 | 0.37832544 |
| 86 | ADRBK2 | 0.37282478 |
| 87 | MAPK13 | 0.36042592 |
| 88 | PRKCD | 0.35542825 |
| 89 | MAP3K7 | 0.34366726 |
| 90 | EPHA3 | 0.34162820 |
| 91 | PRKG2 | 0.32102659 |
| 92 | EPHB1 | 0.31967776 |
| 93 | ROCK1 | 0.30796036 |
| 94 | CDK4 | 0.30783208 |
| 95 | PINK1 | 0.30446445 |
| 96 | FGR | 0.30414242 |
| 97 | CHUK | 0.30035997 |
| 98 | TYRO3 | 0.29835090 |
| 99 | RPS6KA5 | 0.28809455 |
| 100 | ABL1 | 0.28563166 |
| 101 | DAPK2 | 0.25908058 |
| 102 | MAPK7 | 0.25813274 |
| 103 | GRK7 | 0.25681541 |
| 104 | MARK2 | 0.25137706 |
| 105 | MAP3K11 | 0.23996705 |
| 106 | DAPK1 | 0.23831508 |
| 107 | SRC | 0.23312245 |
| 108 | MAPKAPK3 | 0.23175780 |
| 109 | ILK | 0.22848253 |
| 110 | PRKD2 | 0.22193807 |
| 111 | STK16 | 0.22111869 |
| 112 | WNK4 | 0.21710293 |
| 113 | MAP2K3 | 0.21648774 |
| 114 | CDK9 | 0.21514792 |
| 115 | PIM2 | 0.21493849 |
| 116 | PTK2B | 0.20545715 |
| 117 | RAF1 | 0.19494524 |
| 118 | PASK | 0.18880742 |
| 119 | MAPK12 | 0.18617053 |
| 120 | PRKCA | 0.18484973 |
| 121 | TGFBR1 | 0.18313029 |
| 122 | HIPK2 | 0.18022838 |
| 123 | FGFR2 | 0.17031235 |
| 124 | FRK | 0.15804506 |
| 125 | PRKD1 | 0.15407148 |
| 126 | CSNK1G3 | 0.14973863 |
| 127 | SIK2 | 0.14926459 |
| 128 | TAOK2 | 0.14909124 |
| 129 | TNIK | 0.14826957 |
| 130 | INSRR | 0.14553121 |
| 131 | PDGFRB | 0.14422488 |
| 132 | AURKB | 0.13911347 |
| 133 | MAPK3 | 0.13639906 |
| 134 | PDK1 | 0.13593113 |
| 135 | SIK3 | 0.13471981 |
| 136 | CSNK1A1 | 0.11517129 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.30572649 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 6.10720675 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 4.59886290 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.96357210 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.49304379 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.26324774 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.99135951 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.71970096 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.62136901 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.09619939 |
| 11 | Viral myocarditis_Homo sapiens_hsa05416 | 2.08558212 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.00698001 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.99340409 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.85412956 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.76495491 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.61115229 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.55466678 |
| 18 | Ribosome_Homo sapiens_hsa03010 | 1.42849575 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.37813487 |
| 20 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32707542 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32507623 |
| 22 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.32286208 |
| 23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.28636477 |
| 24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26299036 |
| 25 | Proteasome_Homo sapiens_hsa03050 | 1.25612103 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.18738324 |
| 27 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.18137227 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.16288024 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14452358 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.12009982 |
| 31 | HTLV-I infection_Homo sapiens_hsa05166 | 1.07243910 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.07185124 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.06544547 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.03427474 |
| 35 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.94324761 |
| 36 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.92378533 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.91231849 |
| 38 | DNA replication_Homo sapiens_hsa03030 | 0.87273807 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 0.82988260 |
| 40 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.81601584 |
| 41 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79926261 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 0.79399985 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77875967 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.76016527 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 0.75392912 |
| 46 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73861794 |
| 47 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.73776408 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70932119 |
| 49 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70690677 |
| 50 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.70291774 |
| 51 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.69412523 |
| 52 | Mismatch repair_Homo sapiens_hsa03430 | 0.67776127 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 0.65817873 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65758403 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.65587149 |
| 56 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.64564768 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63939595 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63684661 |
| 59 | RNA polymerase_Homo sapiens_hsa03020 | 0.62968307 |
| 60 | Parkinsons disease_Homo sapiens_hsa05012 | 0.62312490 |
| 61 | Spliceosome_Homo sapiens_hsa03040 | 0.57526267 |
| 62 | Salmonella infection_Homo sapiens_hsa05132 | 0.56485518 |
| 63 | * Apoptosis_Homo sapiens_hsa04210 | 0.55281740 |
| 64 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.55233318 |
| 65 | Legionellosis_Homo sapiens_hsa05134 | 0.54576017 |
| 66 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53462350 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 0.52516962 |
| 68 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.52477568 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52018890 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51944706 |
| 71 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.51020030 |
| 72 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.49629405 |
| 73 | Hepatitis C_Homo sapiens_hsa05160 | 0.49574778 |
| 74 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49358030 |
| 75 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48938672 |
| 76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47504464 |
| 77 | Tuberculosis_Homo sapiens_hsa05152 | 0.47461851 |
| 78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45139644 |
| 79 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43459072 |
| 80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41878234 |
| 81 | Protein export_Homo sapiens_hsa03060 | 0.41775003 |
| 82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.41084221 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41073841 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38932454 |
| 85 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.38737449 |
| 86 | Peroxisome_Homo sapiens_hsa04146 | 0.37411822 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.37342296 |
| 88 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.36495681 |
| 89 | Adherens junction_Homo sapiens_hsa04520 | 0.36026146 |
| 90 | RNA degradation_Homo sapiens_hsa03018 | 0.35514776 |
| 91 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.35290941 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33605539 |
| 93 | Phagosome_Homo sapiens_hsa04145 | 0.33121414 |
| 94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.32498442 |
| 95 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.32332012 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31807578 |
| 97 | Base excision repair_Homo sapiens_hsa03410 | 0.31163539 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.30398783 |
| 99 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.29676178 |
| 100 | Olfactory transduction_Homo sapiens_hsa04740 | 0.28779621 |
| 101 | Pertussis_Homo sapiens_hsa05133 | 0.26303952 |
| 102 | Basal transcription factors_Homo sapiens_hsa03022 | 0.23226826 |
| 103 | Alzheimers disease_Homo sapiens_hsa05010 | 0.21303272 |
| 104 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.18112684 |
| 105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.17695858 |
| 106 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.15525276 |
| 107 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.14585313 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.14370696 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14015314 |
| 110 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.13227201 |
| 111 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.12850397 |
| 112 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.11391123 |
| 113 | Purine metabolism_Homo sapiens_hsa00230 | 0.11287241 |
| 114 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.10728358 |
| 115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.10266975 |
| 116 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.09744688 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.09248829 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.09171688 |
| 119 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.07117432 |
| 120 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.07012838 |
| 121 | * Lysosome_Homo sapiens_hsa04142 | 0.06446817 |
| 122 | Homologous recombination_Homo sapiens_hsa03440 | 0.06342058 |
| 123 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.05528382 |
| 124 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.04456356 |
| 125 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.01456325 |
| 126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.00827259 |
| 127 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.00637821 |
| 128 | Pathways in cancer_Homo sapiens_hsa05200 | 0.00141398 |
| 129 | Focal adhesion_Homo sapiens_hsa04510 | 0.00037841 |
| 130 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0351922 |
| 131 | Bladder cancer_Homo sapiens_hsa05219 | -0.0308058 |
| 132 | Thyroid cancer_Homo sapiens_hsa05216 | -0.0225419 |
| 133 | Small cell lung cancer_Homo sapiens_hsa05222 | -0.0212998 |

